said Peter Richardson, MRCP (UK), Executive Vice President & Chief Scientific Officer. Dr. Varkonyi said, "Acute and chronic GvHD, along with TA-TMA, remain unresolved issues following allogeneic bone ...
David Huang, MBBS, MRCP (UK), Ph.D. Laboratory Head, Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. Two decades ago ...